Works matching IS 1470269X AND DT 2013 AND VI 13 AND IP 1

Results: 11

A whole-genome association study of major determinants for allopurinol-related Stevens-Johnson syndrome and toxic epidermal necrolysis in Japanese patients.

Published in:

Pharmacogenomics Journal, 2013, v. 13, n. 1, p. 60, doi. 10.1038/tpj.2011.41

By:

Tohkin, M;
Kaniwa, N;
Saito, Y;
Sugiyama, E;
Kurose, K;
Nishikawa, J;
Hasegawa, R;
Aihara, M;
Matsunaga, K;
Abe, M;
Furuya, H;
Takahashi, Y;
Ikeda, H;
Muramatsu, M;
Ueta, M;
Sotozono, C;
Kinoshita, S;
Ikezawa, Z

Publication type:

Article

Pharmacogenomics of drug-metabolizing enzymes: a recent update on clinical implications and endogenous effects.

Published in:

Pharmacogenomics Journal, 2013, v. 13, n. 1, p. 1, doi. 10.1038/tpj.2012.45

By:

Sim, S C;
Kacevska, M;
Ingelman-Sundberg, M

Publication type:

Article

Serotonin receptor 2A (HTR2A) gene polymorphism predicts treatment response to venlafaxine XR in generalized anxiety disorder.

Published in:

Pharmacogenomics Journal, 2013, v. 13, n. 1, p. 21, doi. 10.1038/tpj.2011.47

By:

Lohoff, F W;
Aquino, T D;
Narasimhan, S;
Multani, P K;
Etemad, B;
Rickels, K

Publication type:

Article

CYP4A11 variant is associated with high-density lipoprotein cholesterol in women.

Published in:

Pharmacogenomics Journal, 2013, v. 13, n. 1, p. 44, doi. 10.1038/tpj.2011.40

By:

White, C C;
Feng, Q;
Cupples, L A;
Gainer, J V;
Dawson, E P;
Wilke, R A;
Brown, N J

Publication type:

Article

Genomics of ADME gene expression: mapping expression quantitative trait loci relevant for absorption, distribution, metabolism and excretion of drugs in human liver.

Published in:

Pharmacogenomics Journal, 2013, v. 13, n. 1, p. 12, doi. 10.1038/tpj.2011.44

By:

Schröder, A;
Klein, K;
Winter, S;
Schwab, M;
Bonin, M;
Zell, A;
Zanger, U M

Publication type:

Article

A genomic approach to predict synergistic combinations for breast cancer treatment.

Published in:

Pharmacogenomics Journal, 2013, v. 13, n. 1, p. 94, doi. 10.1038/tpj.2011.48

By:

Soldi, R;
Cohen, A L;
Cheng, L;
Sun, Y;
Moos, P J;
Bild, A H

Publication type:

Article

DPP6 as a candidate gene for neuroleptic-induced tardive dyskinesia.

Published in:

Pharmacogenomics Journal, 2013, v. 13, n. 1, p. 27, doi. 10.1038/tpj.2011.36

By:

Tanaka, S;
Syu, A;
Ishiguro, H;
Inada, T;
Horiuchi, Y;
Ishikawa, M;
Koga, M;
Noguchi, E;
Ozaki, N;
Someya, T;
Kakita, A;
Takahashi, H;
Nawa, H;
Arinami, T

Publication type:

Article

Genome-wide meta-analysis identifies variants associated with platinating agent susceptibility across populations.

Published in:

Pharmacogenomics Journal, 2013, v. 13, n. 1, p. 35, doi. 10.1038/tpj.2011.38

By:

Wheeler, H E;
Gamazon, E R;
Stark, A L;
O'Donnell, P H;
Gorsic, L K;
Huang, R S;
Cox, N J;
Dolan, M E

Publication type:

Article

Gray matter textural heterogeneity as a potential in-vivo biomarker of fine structural abnormalities in Asperger syndrome.

Published in:

Pharmacogenomics Journal, 2013, v. 13, n. 1, p. 70, doi. 10.1038/tpj.2012.3

By:

Radulescu, E;
Ganeshan, B;
Minati, L;
Beacher, F D C C;
Gray, M A;
Chatwin, C;
Young, R C D;
Harrison, N A;
Critchley, H D

Publication type:

Article

Characterization of the melanocortin-4-receptor nonsense mutation W16X in vitro and in vivo.

Published in:

Pharmacogenomics Journal, 2013, v. 13, n. 1, p. 80, doi. 10.1038/tpj.2011.43

By:

Bolze, F;
Rink, N;
Brumm, H;
Kühn, R;
Mocek, S;
Schwarz, A-E;
Kless, C;
Biebermann, H;
Wurst, W;
Rozman, J;
Klingenspor, M

Publication type:

Article

ITPKC and CASP3 polymorphisms and risks for IVIG unresponsiveness and coronary artery lesion formation in Kawasaki disease.

Published in:

Pharmacogenomics Journal, 2013, v. 13, n. 1, p. 52, doi. 10.1038/tpj.2011.45

By:

Onouchi, Y;
Suzuki, Y;
Suzuki, H;
Terai, M;
Yasukawa, K;
Hamada, H;
Suenaga, T;
Honda, T;
Honda, A;
Kobayashi, H;
Takeuchi, T;
Yoshikawa, N;
Sato, J;
Shibuta, S;
Miyawaki, M;
Oishi, K;
Yamaga, H;
Aoyagi, N;
Iwahashi, S;
Miyashita, R

Publication type:

Article